Macroview Investment Management’s AstraZeneca AZN Stock Holding History

Macroview Investment Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-44	Closed	-$5.96K	–	638
2023 Q3	$5.96K	Buy	+44	New	+$6.01K	0.01%	391
2020 Q2	–	Sell	-32	Closed	-$3K	–	315
2020 Q1	$3K	Hold	32	–	–	0.01%	166
2019 Q4	$3K	Hold	32	–	–	0.01%	226
2019 Q3	$3K	Hold	32	–	–	0.01%	220
2019 Q2	$3K	Hold	32	–	–	0.01%	226
2019 Q1	$3K	Hold	32	–	–	0.01%	228
2018 Q4	$2K	Hold	32	–	–	0.01%	253
2018 Q3	$2K	Buy	+32	New	+$2.42K	0.01%	270
2015 Q1	–	Sell	-16	Closed	-$1K	–	141
2014 Q4	$1K	Hold	16	–	–	﹤0.01%	147
2014 Q3	$1K	Buy	+16	New	+$1.17K	﹤0.01%	157

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Macroview Investment Management's AZN Position: Q4 2023 in Review

Macroview Investment Management sold out of AstraZeneca (AZN) in Q4 2023, closing a stake of 44 shares — an estimated $5.96K sold.

Macroview Investment Management first reported a position in AZN in Q3 2014 and held it in 10 quarters. The position peaked at $5.96K in Q3 2023. 1,130 funds tracked by Wall St. Rank hold AZN as of Q4 2023.

Macroview Investment Management reported no remaining AstraZeneca position as of Q4 2023 after selling out during the quarter.
Macroview Investment Management sold 44 AstraZeneca shares in Q4 2023, an estimated $5.96K.
Macroview Investment Management first reported a position in AstraZeneca in Q3 2014 and held it in 10 quarters.
Macroview Investment Management's AstraZeneca position peaked at $5.96K in Q3 2023.
1,130 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2023.

Based on Macroview Investment Management's 13F filing for Q4 2023, filed 30 Jan 2024.